It refers to an agommelatine form of crystal, which is characterized by the following diffraction angle 2 theta: 11.13 shown in the X-ray powder diffraction pattern；11.82 degrees17.49%19.48%19.72.20.50%21.76%22.54%22.97 degrees24.56%25.36%27.16 and 31.93 degrees In addition to a prep program and a pharmaceutical composer. This crystal form has high purity, stability and replicability, which is beneficial to drug formulationSE REFIERE A UNA FORMA CRISTALINA DE AGOMELATINA CARACTERIZADA PORQUE EN EL DIAGRAMA DE DIFRACCION DE RAYOS X EN POLVO PRESENTA LOS SIGUIENTES ANGULOS DE DIFRACCION 2 THETA: 11,13º； 11,82º； 17,49º； 19,48º； 19,72º； 20,50º； 21,76º； 22,54º； 22,97º, 24,56º； 25,36º； 27,16º Y 31,93º. REFERIDA ADEMAS A UN PROCEDIMENTO DE PREPARACION Y UNA COMPOSICION FARMACEUTICA. DICHA FORMA CRISTALINA PRESETNA UNA ALTA PUREZA, ESTABILIDAD Y BUENA REPRODUCIBILIDAD SIENDO VENTAJOSA PARA LA FORMULACION FARMACEUTICA
